Try our Advanced Search for more refined results
In Re Vitamin C Antitrust Litigation
Case Number:
1:06-md-01738
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Amamgbo & Associates
- Baker McKenzie
- BoiesBattin
- Boies Schiller
- Cadwalader Wickersham
- Cohen Milstein
- Gibbs & Bruns
- Glancy Prongay
- Greenberg Traurig
- Gustafson Gluek
- Hausfeld LLP
- Hofheimer Gartlir
- Houser LLP
- Izower Feldman
- Johns Flaherty
- Joseph Saveri Law Firm
- Kirby McInerney
- Kobre & Kim
- Lieff Cabraser
- Massey & Gail
- Morris Laing
- Moscone Emblidge
- Orrick Herrington
- Paul Weiss
- Saveri & Saveri
- Seward & Kissel
- Sidley Austin
- Slinde Nelson
- Susman Godfrey
- Wilson Sonsini
- Zelle LLP
-
August 14, 2015
Judge Eyes Receivership For 'Derelict' Chinese Vitamin C Cos.
The Brooklyn federal judge overseeing vitamin C price-fixing litigation said Friday he was tempted to place two Chinese judgment debtors into receivership as plaintiffs expressed frustration at their inability to collect on a damages award approaching $160 million in value.
-
April 17, 2015
Cos. Say China Blocked Vitamin C Antitrust Suit Compliance
Two Chinese companies urged a New York federal judge Friday to deny a bid by a group of U.S. businesses to sanction them for refusing to turn over financial documents in a vitamin C price-fixing suit, saying the Chinese government has prohibited them from doing so.
-
March 23, 2015
Contempt Sought In $150M Chinese Vitamin C Antitrust Case
A group of U.S. businesses urged a New York federal judge to sanction two Chinese companies, saying each has refused to turn over financial documents after being hit with a verdict that topped $150 million in a vitamin C price-fixing suit.
-
January 02, 2014
Judgment Boosted To $157M In Vitamin C Antitrust Case
A New York federal judge on Monday added $4 million in attorneys' fees to the $153 million price-fixing verdict against vitamin C company North China Pharmaceutical Group Corp. and awarded the plaintiffs interest.
-
December 16, 2013
Chinese Co. To Pay $2.2M To End Vitamin C Antitrust Case
Weisheng Pharmaceutical Co. Ltd. and parent company CSPC Pharmaceutical Group Ltd., formerly known as China Pharmaceutical Group Ltd., have agreed to pay $2.2 million to settle with consumers and other indirect purchasers over claims that they conspired to fix vitamin C prices, the plaintiffs said Friday.
-
November 26, 2013
Hebei Can't Dodge $153M Penalty In Vitamin C Class Action
A New York federal judge on Tuesday refused to toss a $153.3 million award against Hebei Welcome Pharmaceutical Co. Ltd. and North China Pharmaceutical Group Corp. in a class action over vitamin C price-fixing claims, finding a jury wasn't improperly blocked from evidence.
-
October 03, 2013
Vitamin C Attys Get $10M For Work On Antitrust Settlements
A New York federal judge on Wednesday approved a $10 million attorney award and granted final approval to a $23 million settlement that allowed China Pharmaceutical Group Ltd. to step out of a class action over vitamin C price-fixing claims.
-
June 03, 2013
Vitamin C Co. Pushes To Ax $153M Antitrust Award
North China Pharmaceutical Group Corp. urged a New York federal court Friday to toss a $153 million damages award against the company because the recent vitamin C price-fixing trial improperly passed judgment on the Chinese government's export policies.
-
May 13, 2013
Vitamin C Classes Blast Bid To Nix $153M Antitrust Verdict
The class alleging North China Pharmaceutical Group Corp. and its vitamin C unit fixed prices pushed back Friday against NCPG's bid to dismiss the suit in New York federal court and toss a recent $153 million damages award, saying China didn't compel the companies' illegal conduct.
-
April 11, 2013
Chinese Co. Wants $153M Award Vacated In Vitamin C MDL
North China Pharmaceutical Group Corp. on Thursday asked a New York federal judge to vacate a recent $153 million award and dismiss multidistrict antitrust litigation alleging illegal collusion in China's vitamin C industry, claiming that only NCPG's indirectly owned subsidiary was involved in the scheme.